SCHEMBL9498449

SCHEMBL9498449

CCn1ccnc1C(=O)c1nccn1CC

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.41
MAPT P10636 1/20 0.38
KMT2A Q03164 2/20 0.37
ALDH1A1 P00352 1/20 0.37
POLB P06746 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
PKM P14618 1/20 0.37
CYP2C19 P33261 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
ALPG P10696 2/20 0.36
PLAA Q9Y263 1/20 0.36
TLR8 Q9NR97 1/20 0.35
FDPS P14324 1/20 0.35
ALPL P05186 1/20 0.35
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2276496 0.86 SMN1; SMN2 (0.40) SMN1; SMN2MAPTKMT2AALDH1A1POLB
SCHEMBL300078 0.86 SMN1; SMN2 (0.47) SMN1; SMN2MAPTKMT2AALDH1A1POLB
SCHEMBL13724404 0.84 SMN1; SMN2 (0.39) SMN1; SMN2MAPTKMT2AALDH1A1POLB
SCHEMBL4314338 0.84 SMN1; SMN2 (0.39) SMN1; SMN2MAPTKMT2AALDH1A1POLB
SCHEMBL370634 0.82 SMN1; SMN2 (0.41) SMN1; SMN2MAPTKMT2AALDH1A1POLB
SCHEMBL25153633 0.81 LPO (0.40) SMN1; SMN2MAPTALDH1A1NPC1RAB9A
SCHEMBL5518077 0.81 SMN1; SMN2 (0.41) SMN1; SMN2MAPTKMT2AALDH1A1POLB
SCHEMBL12499907 0.81 MAPT (0.41) SMN1; SMN2MAPTKMT2AALDH1A1POLB
Hydrochloric Acid SCHEMBL1982420 0.80 SMN1; SMN2 (0.40) SMN1; SMN2MAPTKMT2AALDH1A1POLB
SCHEMBL12706154 0.80 LPO (0.42) MAPTKMT2AALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5236952-A Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa HOFFMANN-LA ROCHE INC. (US) 1993-08-17 US disclosed